{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:38:25Z","timestamp":1794440305582,"version":"4.9.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["10.55776\/FG20"],"award-info":[{"award-number":["10.55776\/FG20"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["10.55776\/P36600"],"award-info":[{"award-number":["10.55776\/P36600"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["10.55776\/ESP634"],"award-info":[{"award-number":["10.55776\/ESP634"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["302452"],"award-info":[{"award-number":["302452"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiple myeloma (MM) is characterized by the production and secretion of large quantities of immunoglobulins, making this malignancy highly dependent on mechanisms that maintain cellular proteostasis. While significant clinical progress has been made by targeting the degradative branch of proteostasis, much less attention has been given to the biosynthetic branch. In this study, we demonstrated that inhibiting COPII-dependent endoplasmic reticulum (ER) export induces cell death in several MM cell lines and primary patient-derived cells. The induction of cell death was dependent on the secretory status of MM cells. Blocking ER export in secretory MM cells caused the accumulation of misfolded proteins, which activated ER-associated degradation (ERAD). Consequently, we observed an ERAD-dependent increase in the levels of free cytosolic amino acids and a subsequent activation of mTORC1 signaling. Simultaneously, we observed mitochondrial dysfunction. These alterations resulted in a mismatch between the increased energy demand due to mTORC1 activation, and the disrupted energy supply from mitochondrial impairment. This energetic imbalance results in homeostatic collapse and cell death of secretory MM cells. The therapeutic potential of the concept was demonstrated in two in vivo myeloma models. These findings suggest that the ER export machinery could be a promising therapeutic target in multiple myeloma.<\/jats:p>","DOI":"10.1038\/s41392-026-02833-y","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:29:25Z","timestamp":1783380565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeting endoplasmic reticulum export disrupts metabolic resilience in multiple myeloma"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6747-3043","authenticated-orcid":false,"given":"Utku","family":"Horzum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0963-8268","authenticated-orcid":false,"given":"Herbert","family":"Oberacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Haun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Geley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7650-1441","authenticated-orcid":false,"given":"Monica","family":"Roman-Trufero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4040-0642","authenticated-orcid":false,"given":"Holger","family":"Auner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5781-9995","authenticated-orcid":false,"given":"Agnieszka","family":"Martowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3430-119X","authenticated-orcid":false,"given":"Gerold","family":"Untergasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1327-2921","authenticated-orcid":false,"given":"Eberhard","family":"Gunsilius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7702-1721","authenticated-orcid":false,"given":"Wolfgang","family":"Willenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1066-552X","authenticated-orcid":false,"given":"Hamdullah","family":"Yanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4865-2377","authenticated-orcid":false,"given":"Gunes","family":"Esendagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4761-075X","authenticated-orcid":false,"given":"Dominik","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0889-8463","authenticated-orcid":false,"given":"Hesso","family":"Farhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"2833_CR1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","volume":"397","author":"NWCJ van de Donk","year":"2021","unstructured":"van de Donk, N. W. C. J., Pawlyn, C. & Yong, K. L. Multiple myeloma. Lancet 397, 410\u2013427 (2021).","journal-title":"Lancet"},{"key":"2833_CR2","first-page":"1","volume":"14","author":"CFM Hughes","year":"2024","unstructured":"Hughes, C. F. M., Shah, G. L. & Paul, B. A. Autologous hematopoietic stem cell transplantation for multiple myeloma in the age of CAR T cell therapy. Front. Oncol. 14, 1\u201310 (2024).","journal-title":"Front. Oncol."},{"key":"2833_CR3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1182\/bloodadvances.2018019851","volume":"3","author":"XQ Qin","year":"2019","unstructured":"Qin, X. Q. et al. Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective study. Blood Adv. 3, 751\u2013760 (2019).","journal-title":"Blood Adv."},{"key":"2833_CR4","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114740","volume":"14","author":"A Domenger","year":"2022","unstructured":"Domenger, A. et al. The Sec 61 translocon is a therapeutic vulnerability in multiple myeloma. EMBO Mol. Med. 14, e14740 (2022).","journal-title":"EMBO Mol. Med."},{"key":"2833_CR5","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1158\/0008-5472.CAN-15-3099","volume":"76","author":"S Vatolin","year":"2016","unstructured":"Vatolin, S. et al. Novel protein disulfide isomerase inhibitor with anticancer activity in multiple myeloma. Cancer Res. 76, 3340\u20133350 (2016).","journal-title":"Cancer Res."},{"key":"2833_CR6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/tra.12654","volume":"20","author":"J Peotter","year":"2019","unstructured":"Peotter, J., Kasberg, W., Pustova, I. & Audhya, A. COPII-mediated trafficking at the ER\/ERGIC interface. Traffic 20, 491\u2013503 (2019).","journal-title":"Traffic"},{"key":"2833_CR7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/s41580-025-00899-0","volume":"26","author":"H Farhan","year":"2025","unstructured":"Farhan, H. et al. Towards a unified framework for the function of endoplasmic reticulum exit sites. Nat. Rev. Mol. Cell Biol. 26, 957\u2013969 (2025).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2833_CR8","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1038\/emboj.2008.208","volume":"27","author":"JD Mancias","year":"2008","unstructured":"Mancias, J. D. & Goldberg, J. Structural basis of cargo membrane protein discrimination by the human COPII coat machinery. EMBO J. 27, 2918\u20132928 (2008).","journal-title":"EMBO J."},{"key":"2833_CR9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/tra.12817","volume":"22","author":"S Chatterjee","year":"2021","unstructured":"Chatterjee, S., Choi, A. J. & Frankel, G. A systematic review of Sec24 cargo interactome. Traffic 22, 412\u2013424 (2021).","journal-title":"Traffic"},{"key":"2833_CR10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2141.1989.tb00252.x","volume":"73","author":"T Ohtsuki","year":"1989","unstructured":"Ohtsuki, T. et al. Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32). Br. J. Haematol. 73, 199\u2013204 (1989).","journal-title":"Br. J. Haematol."},{"key":"2833_CR11","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ncb2510","volume":"14","author":"JC Simpson","year":"2012","unstructured":"Simpson, J. C. et al. Genome-wide RNAi screening identifies human proteins with a regulatory function in the early secretory pathway. Nat. Cell Biol. 14, 764\u2013774 (2012).","journal-title":"Nat. Cell Biol."},{"key":"2833_CR12","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1038\/sj.emboj.7601844","volume":"26","author":"T Anelli","year":"2007","unstructured":"Anelli, T. et al. Sequential steps and checkpoints in the early exocytic compartment during secretory IgM biogenesis. EMBO J. 26, 4177\u20134188 (2007).","journal-title":"EMBO J."},{"key":"2833_CR13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1600-0854.2010.01043.x","volume":"11","author":"M Cortini","year":"2010","unstructured":"Cortini, M. & Sitia, R. ERp44 and ERGIC-53 synergize in coupling efficiency and fidelity of IgM polymerization and secretion. Traffic 11, 651\u2013659 (2010).","journal-title":"Traffic"},{"key":"2833_CR14","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/j.1460-2075.1986.tb04385.x","volume":"5","author":"AM Tartakoff","year":"1986","unstructured":"Tartakoff, A. M. Temperature and energy dependence of secretory protein transport in the exocrine pancreas. EMBO J. 5, 1477\u20131482 (1986).","journal-title":"EMBO J."},{"key":"2833_CR15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1034\/j.1600-0854.2002.31108.x","volume":"3","author":"A Mezzacasa","year":"2002","unstructured":"Mezzacasa, A. & Helenius, A. The transitional ER defines a boundary for quality control in the secretion of tsO45 VSV glycoprotein. Traffic 3, 833\u2013849 (2002).","journal-title":"Traffic"},{"key":"2833_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.27518","volume":"6","author":"A Bakunts","year":"2017","unstructured":"Bakunts, A. et al. Ratiometric sensing of BiP-client versus BiP levels by the unfolded protein response determines its signaling amplitude. Elife 6, 1\u201321 (2017).","journal-title":"Elife"},{"key":"2833_CR17","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/emboj.2008.136","volume":"27","author":"H Farhan","year":"2008","unstructured":"Farhan, H., Weiss, M., Tani, K., Kaufman, R. J. & Hauri, H. P. Adaptation of endoplasmic reticulum exit sites to acute and chronic increases in cargo load. EMBO J. 27, 2043\u20132054 (2008).","journal-title":"EMBO J."},{"key":"2833_CR18","volume":"8","author":"MZ Chen","year":"2017","unstructured":"Chen, M. Z. et al. A thiol probe for measuring unfolded protein load and proteostasis in cells. Nat. Commun. 8, 474 (2017).","journal-title":"Nat. Commun."},{"key":"2833_CR19","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/emboj.2009.117","volume":"28","author":"CCA Hu","year":"2009","unstructured":"Hu, C. C. A., Dougan, S. K., McGehee, A. M., Love, J. C. & Ploegh, H. L. XBP-1 regulates signal transduction, transcription factors and bone marrow colonization in B cells. EMBO J. 28, 1624\u20131636 (2009).","journal-title":"EMBO J."},{"key":"2833_CR20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ni907","volume":"4","author":"NN Iwakoshi","year":"2003","unstructured":"Iwakoshi, N. N. et al. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-I. Nat. Immunol. 4, 321\u2013329 (2003).","journal-title":"Nat. Immunol."},{"key":"2833_CR21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.immuni.2004.06.010","volume":"21","author":"AL Shaffer","year":"2004","unstructured":"Shaffer, A. L. et al. XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 21, 81\u201393 (2004).","journal-title":"Immunity"},{"key":"2833_CR22","doi-asserted-by":"crossref","first-page":"22414","DOI":"10.1074\/jbc.M116.732511","volume":"291","author":"J Dyachok","year":"2016","unstructured":"Dyachok, J., Earnest, S., Iturraran, E. N., Cobb, M. H. & Ross, E. M. Amino acids regulate mTORC1 by an obligate two-step mechanism. J. Biol. Chem. 291, 22414\u201322426 (2016).","journal-title":"J. Biol. Chem."},{"key":"2833_CR23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/cr.2015.146","volume":"26","author":"M Shimobayashi","year":"2016","unstructured":"Shimobayashi, M. & Hall, M. N. Multiple amino acid sensing inputs to mTORC1. Cell Res. 26, 7\u201320 (2016).","journal-title":"Cell Res."},{"key":"2833_CR24","doi-asserted-by":"crossref","first-page":"1159409","DOI":"10.3389\/fphar.2023.1159409","volume":"14","author":"S Hanson","year":"2023","unstructured":"Hanson, S. et al. Paraptosis: a unique cell death mode for targeting cancer. Front. Pharmacol. 14, 1159409 (2023).","journal-title":"Front. Pharmacol."},{"key":"2833_CR25","first-page":"57","volume":"26","author":"RG Lee","year":"2023","unstructured":"Lee, R. G. et al. Quantitative subcellular reconstruction reveals a lipid mediated inter-organelle biogenesis network. Nat. Cell Biol. 26, 57\u201371 (2023).","journal-title":"Nat. Cell Biol."},{"key":"2833_CR26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1074-7613(03)00051-7","volume":"18","author":"MF Princiotta","year":"2003","unstructured":"Princiotta, M. F. et al. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18, 343\u2013354 (2003).","journal-title":"Immunity"},{"key":"2833_CR27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nmeth.1314","volume":"6","author":"EK Schmidt","year":"2009","unstructured":"Schmidt, E. K., Clavarino, G., Ceppi, M. & Pierre, P. SUnSET, a nonradioactive method to monitor protein synthesis. Nat. Methods 6, 275\u2013277 (2009).","journal-title":"Nat. Methods"},{"key":"2833_CR28","doi-asserted-by":"crossref","unstructured":"Martowicz, A., Kern, J., Gunsilius, E. & Untergasser, G. Establishment of a human multiple myeloma xenograft model in the chicken to study tumor growth, invasion and angiogenesis. J. Vis. Exp. 99, e52665 (2015).","DOI":"10.3791\/52665-v"},{"key":"2833_CR29","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood-2012-05-425934","volume":"120","author":"DS Siegel","year":"2012","unstructured":"Siegel, D. S. et al. A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma. Blood 120, 2817\u20132825 (2012).","journal-title":"Blood"},{"key":"2833_CR30","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-06-2258","volume":"67","author":"S Meister","year":"2007","unstructured":"Meister, S. et al. Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition. Cancer Res. 67, 1783\u20131792 (2007).","journal-title":"Cancer Res."},{"key":"2833_CR31","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1182\/blood-2008-08-172734","volume":"113","author":"G Bianchi","year":"2009","unstructured":"Bianchi, G. et al. The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition. Blood 113, 3040\u20133049 (2009).","journal-title":"Blood"},{"key":"2833_CR32","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1080\/15548627.2015.1052928","volume":"11","author":"E Milan","year":"2015","unstructured":"Milan, E. et al. A plastic SQSTM1\/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells. Autophagy 11, 1161\u20131178 (2015).","journal-title":"Autophagy"},{"key":"2833_CR33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s10875-016-0254-9","volume":"36","author":"E Milan","year":"2016","unstructured":"Milan, E., Fabbri, M. & Cenci, S. Autophagy in plasma cell ontogeny and malignancy. J. Clin. Immunol. 36, 18\u201324 (2016).","journal-title":"J. Clin. Immunol."},{"key":"2833_CR34","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1182\/bloodadvances.2021006638","volume":"7","author":"S Li","year":"2023","unstructured":"Li, S. et al. Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects. Blood Adv. 7, 2926\u20132937 (2023).","journal-title":"Blood Adv."},{"key":"2833_CR35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal2668","volume":"9","author":"S Manier","year":"2017","unstructured":"Manier, S. et al. Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma. Sci. Transl. Med. 9, eadp8818 (2017).","journal-title":"Sci. Transl. Med."},{"key":"2833_CR36","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/s41375-025-02682-8","volume":"39","author":"TK V\u00e5tsveen","year":"2025","unstructured":"V\u00e5tsveen, T. K. et al. Targeting proteostasis in multiple myeloma through inhibition of LTK. Leukemia 39, 2237\u20132245 (2025).","journal-title":"Leukemia"},{"key":"2833_CR37","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/eji.201142192","volume":"42","author":"YC Lee","year":"2012","unstructured":"Lee, Y. C. et al. Paxillin phosphorylation by JNK and p38 is required for NFAT activation. Eur. J. Immunol. 42, 2165\u20132175 (2012).","journal-title":"Eur. J. Immunol."},{"key":"2833_CR38","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrg2662","volume":"10","author":"D Allan Drummond","year":"2009","unstructured":"Allan Drummond, D. & Wilke, C. O. The evolutionary consequences of erroneous protein synthesis. Nat. Rev. Genet. 10, 715\u2013724 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"2833_CR39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/bit.27196","volume":"117","author":"S Mathias","year":"2020","unstructured":"Mathias, S. et al. Unraveling what makes a monoclonal antibody difficult-to-express: From intracellular accumulation to incomplete folding and degradation via ERAD. Biotechnol. Bioeng. 117, 5\u201316 (2020).","journal-title":"Biotechnol. Bioeng."},{"key":"2833_CR40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bjh.13172","volume":"168","author":"HW Auner","year":"2015","unstructured":"Auner, H. W. & Cenci, S. Recent advances and future directions in targeting the secretory apparatus in multiple myeloma. Br. J. Haematol. 168, 14\u201325 (2015).","journal-title":"Br. J. Haematol."},{"key":"2833_CR41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41556-018-0205-1","volume":"21","author":"J Kim","year":"2019","unstructured":"Kim, J. & Guan, K. L. mTOR as a central hub of nutrient signalling and cell growth. Nat. Cell Biol. 21, 63\u201371 (2019).","journal-title":"Nat. Cell Biol."},{"key":"2833_CR42","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18504-7","volume":"11","author":"N Gremke","year":"2020","unstructured":"Gremke, N. et al. mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability. Nat. Commun. 11, 4684 (2020).","journal-title":"Nat. Commun."},{"key":"2833_CR43","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.4161\/auto.7.10.16681","volume":"7","author":"S Ng","year":"2011","unstructured":"Ng, S., Wu, Y. T., Chen, B., Zhou, J. & Shen, H. M. Impaired autophagy due to constitutive mTOR activation sensitizes TSC2-null cells to cell death under stress. Autophagy 7, 1173\u20131186 (2011).","journal-title":"Autophagy"},{"key":"2833_CR44","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14124","volume":"8","author":"VH Villar","year":"2017","unstructured":"Villar, V. H. et al. MTORC1 inhibition in cancer cells protects from glutaminolysis-mediated apoptosis during nutrient limitation. Nat. Commun. 8, 14124 (2017).","journal-title":"Nat. Commun."},{"key":"2833_CR45","first-page":"1","volume":"12","author":"T Yuan","year":"2021","unstructured":"Yuan, T. et al. The Hippo kinase LATS2 impairs pancreatic \u03b2-cell survival in diabetes through the mTORC1-autophagy axis. Nat. Commun. 12, 1\u201318 (2021).","journal-title":"Nat. Commun."},{"key":"2833_CR46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s42255-019-0162-4","volume":"2","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. High-protein diets increase cardiovascular risk by activating macrophage mTOR to suppress mitophagy. Nat. Metab. 2, 110\u2013125 (2020).","journal-title":"Nat. Metab."},{"key":"2833_CR47","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1074\/jbc.M114.605345","volume":"290","author":"SUR Mir","year":"2015","unstructured":"Mir, S. U. R. et al. Inhibition of autophagic turnover in \u03b2-cells by fatty acids and glucose leads to apoptotic cell death. J. Biol. Chem. 290, 6071\u20136085 (2015).","journal-title":"J. Biol. Chem."},{"key":"2833_CR48","first-page":"6077570","volume":"2022","author":"H Wang","year":"2022","unstructured":"Wang, H. et al. mTOR modulates the endoplasmic reticulum stress-induced CD4+ T cell apoptosis mediated by ROS in septic immunosuppression. Mediat. Inflamm. 2022, 6077570 (2022).","journal-title":"Mediat. Inflamm."},{"key":"2833_CR49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10495-020-01655-9","volume":"26","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. Honokiol induces paraptosis-like cell death of acute promyelocytic leukemia via mTOR & MAPK signaling pathways activation. Apoptosis 26, 195\u2013208 (2021).","journal-title":"Apoptosis"},{"key":"2833_CR50","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05421-4","volume":"13","author":"O Darawshi","year":"2022","unstructured":"Darawshi, O. et al. An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma. Cell Death Dis. 13, 969 (2022).","journal-title":"Cell Death Dis."},{"key":"2833_CR51","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/cdd.2011.98","volume":"19","author":"H Kato","year":"2012","unstructured":"Kato, H. et al. MTORC1 serves ER stress-triggered apoptosis via selective activation of the IRE1-JNK pathway. Cell Death Differ. 19, 310\u2013320 (2012).","journal-title":"Cell Death Differ."},{"key":"2833_CR52","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu, Y., Azizian, N. G., Sullivan, D. K. & Li, Y. mTOR inhibition attenuates chemosensitivity through the induction of chemotherapy resistant persisters. Nat. Commun. 13, 7047 (2022).","journal-title":"Nat. Commun."},{"key":"2833_CR53","first-page":"1","volume":"9","author":"Z Li","year":"2021","unstructured":"Li, Z. et al. IRE1-mTOR-PERK axis coordinates autophagy and ER Stress-apoptosis induced by P2X7-Mediated Ca2+ Influx in osteoarthritis. Front. Cell Dev. Biol. 9, 1\u201318 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"2833_CR54","volume":"10","author":"C Fang","year":"2021","unstructured":"Fang, C. et al. IFN-\u03b3-induced ER stress impairs autophagy and triggers apoptosis in lung cancer cells. Oncoimmunology 10, 1962591 (2021).","journal-title":"Oncoimmunology"},{"key":"2833_CR55","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1038\/sj.emboj.7601900","volume":"26","author":"CH Lee","year":"2007","unstructured":"Lee, C. H. et al. Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53. EMBO J. 26, 4812\u20134823 (2007).","journal-title":"EMBO J."},{"key":"2833_CR56","first-page":"1","volume":"9","author":"Y Sakai","year":"2019","unstructured":"Sakai, Y. et al. Hyperactivation of mTORC1 disrupts cellular homeostasis in cerebellar Purkinje cells. Sci. Rep. 9, 1\u201314 (2019).","journal-title":"Sci. Rep."},{"key":"2833_CR57","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nature11745","volume":"493","author":"A Efeyan","year":"2013","unstructured":"Efeyan, A. et al. Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival. Nature 493, 679\u2013683 (2013).","journal-title":"Nature"},{"key":"2833_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-25079-4","volume":"12","author":"C Bodineau","year":"2021","unstructured":"Bodineau, C. et al. Two parallel pathways connect glutamine metabolism and mTORC1 activity to regulate glutamoptosis. Nat. Commun. 12, 1\u201313 (2021).","journal-title":"Nat. Commun."},{"key":"2833_CR59","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1083\/jcb.201610113","volume":"216","author":"B Carroll","year":"2017","unstructured":"Carroll, B. et al. Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing. J. Cell Biol. 216, 1949\u20131957 (2017).","journal-title":"J. Cell Biol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02833-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02833-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02833-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:29:41Z","timestamp":1783380581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02833-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2833"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02833-y","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"262"}}